Results 271 to 280 of about 81,119 (304)

Pre-exposure prophylaxis in the perinatal period

The Lancet HIV
Women in sub-Saharan Africa are at high risk for HIV acquisition during pregnancy and postpartum periods, which puts the health of perinatal people at risk, but also contributes to new paediatric infections. Pre-exposure prophylaxis (PrEP) to prevent HIV is a highly effective intervention to prevent HIV acquisition.
Sheree, Schwartz, Friday, Saidi
openaire   +2 more sources

Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis

International Journal of STD & AIDS, 2015
Pre-exposure prophylaxis (PrEP) has been shown to reduce the risk of HIV transmission but has the potential to cause harm if not used properly. Pharmacists are well-positioned to foster PrEP’s efficacy but little is known whether they would endorse it as an HIV prevention tool.
Deborah, Yoong, Mark, Naccarato, Malika, Sharma, James, Wilton, Heather, Senn, Darrell Hs, Tan   +5 more
openaire   +2 more sources

The FACTS about women and pre-exposure prophylaxis

The Lancet HIV, 2015
The Editorial in the April issue, Antiretroival gels: facing the FACTS, describes the HIV community’s collective disappointment regarding the FACTS trial’s negative results. However, the conclusions that gels are not “practically feasible” and vaginal rings may be the “usable prevention strategy” that women need is misguided.
Dominika, Seidman, Shannon, Weber, Erika, Aaron, Deborah, Cohan, Robert, Grant   +4 more
openaire   +2 more sources

Updates in pre-exposure prophylaxis for HIV

The Lancet Infectious Diseases, 2022
Ammara, Mushtaq, Farooq, Kazi
openaire   +2 more sources

Online Prescriptions to HIV Pre-Exposure Prophylaxis and Pre-Exposure Prophylaxis Uptake

AIDS Patient Care and STDs, 2020
Lexie, Wille, Mike C, Parent
openaire   +2 more sources

[Focus on pre-exposure prophylaxis].

Revue de l'infirmiere, 2013
Pre-exposure prophylaxis currently has no market authorisation in France, but is still evaluated. This article presents an additional tool for risk reduction, currently the subject of studies.
Emma, Torres, Jean-Luc, Meynard
openaire   +1 more source

Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide

Cell, 2022
Jing Xue, Yuanmei Zhu, Jingjing Zhang
exaly  

Pre-Exposure Prophylaxis for HIV

American Journal of Preventive Medicine, 2013
James W. Curran, Richard A. Crosby
openaire   +2 more sources

HIV incidence after pre-exposure prophylaxis initiation among women and men at elevated HIV risk: A population-based study in rural Kenya and Uganda

PLoS Medicine, 2021
Catherine A Koss, Diane V Havlir, James Ayieko   +2 more
exaly  

Pre-exposure prophylaxis (PrEP) and ‘risk’ in the news

Journal of Risk Research, 2022
Luke Collins
exaly